Log In
Print
BCIQ
Print
Print this Print this
 

RQ-00000010

  Manage Alerts
Collapse Summary General Information
Company RaQualia Pharma Inc.
DescriptionSerotonin 5-HT4 partial agonist
Molecular Target Serotonin (5-HT4) receptor
Mechanism of ActionSerotonin (5-HT4) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationGastroesophageal reflux disease (GERD)
Indication DetailsTreat gastroesophageal reflux disease (GERD)
Regulatory Designation

Partner

CJ Group


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today